Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use

Beatrice A Chen; Thomas Kimble; Lisa H Harris; Jennifer L Kerns; Andrea I Olariu; Mitchell D Creinin

doi:10.1097/AOG.0000000000005147

Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use

Obstet Gynecol. 2023 May 1;141(5):1004-1006. doi: 10.1097/AOG.0000000000005147. Epub 2023 Apr 5.

Authors

Beatrice A Chen¹, Thomas Kimble, Lisa H Harris, Jennifer L Kerns, Andrea I Olariu, Mitchell D Creinin

Affiliation

¹ Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh/Magee-Womens Research Institute, Pittsburgh, Pennsylvania; the Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia; the Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan; and the Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, and Medicines360, San Francisco, and the Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, California.

PMID: 37023451
DOI: 10.1097/AOG.0000000000005147

Abstract

Funding source: Medicines360. The Sponsor, Medicines360, designed the study and oversaw its conduct, including funding the trial and providing all study product free of charge to participants.

Clinical trial registration: ClinicalTrials.gov, NCT00995150.

Publication types

Clinical Study
Research Support, Non-U.S. Gov't

MeSH terms

Contraceptive Agents, Female* / adverse effects
Female
Humans
Intrauterine Devices*
Intrauterine Devices, Medicated* / adverse effects
Levonorgestrel / adverse effects
Time Factors

Substances

Contraceptive Agents, Female
Levonorgestrel

Associated data

ClinicalTrials.gov/NCT00995150